RhBMP-2 Is superior to iliac crest bone graft for long fusions to the sacrum in adult spinal deformity

Spine

Volumn 38, Issue 14, 2013, Pages 1209-1215

  Kim, Han Jo ^a   Buchowski, Jacob M ^a   Zebala, Lukas P ^a   Dickson, Douglas D ^a   Koester, Linda ^a   Bridwell, Keith H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adult deformity; Bone morphogenetic protein; Complications; Fusion; Pseudarthrosis

Indexed keywords

ANTIBIOTIC AGENT; APROTININ; COLLAGEN SPONGE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ACOUSTIC NEURINOMA; ACUTE KIDNEY FAILURE; ADULT; ADULT DISEASE; ANTERIOR SPINE FUSION; ARTICLE; BODY MASS; BONE GRAFT; CASE CONTROL STUDY; COBB ANGLE; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE EFFECTIVENESS; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEBRIDEMENT; DEEP VEIN THROMBOSIS; DEHYDRATION; FEMALE; FUNCTIONAL STATUS; HUMAN; ILIAC CREST; ILIAC CREST BONE GRAFT; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OSWESTRY DISABILITY INDEX; POSTERIOR SPINE FUSION; POSTOPERATIVE INFECTION; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PSEUDARTHROSIS; RESPIRATORY FAILURE; SACRUM; SCOLIOSIS RESEARCH SOCIETY SCORE; SCORING SYSTEM; SELF CONCEPT; SKIN CARCINOMA; SMOKING; SPINE MALFORMATION; TREATMENT OUTCOME; UTERUS MYOMA; VENA CAVA FILTER; WOUND IRRIGATION;

ADULT; BONE MORPHOGENETIC PROTEIN 2; BONE TRANSPLANTATION; COHORT STUDIES; DISABILITY EVALUATION; FOLLOW-UP STUDIES; HUMANS; ILIUM; MIDDLE AGED; PSEUDARTHROSIS; RECOMBINANT PROTEINS; SACRUM; SCOLIOSIS; SPINAL FUSION; SPINE; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME;

EID: 84880075894     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e31828b656d     Document Type: Article

References (28)

1. Malloy KM, Hilibrand AS. Autograft versus allograft in degenerative cervical disease. Clin Orthop Relat Res 2002; 394 : 27- 38. (Pubitemid 34062706)
2. Cohen DB, Chotivichit A, Fujita T, et al. Pseudarthrosis repair. Autogenous iliac crest versus femoral ring allograft. Clin Orthop Relat Res 2000; 371 : 46- 55. (Pubitemid 30090820)
3. Boden SD, Martin GJ Jr, Horton WC, et al. Laparoscopic anterior spinalarthrodesis with rhBMP-2 in a titanium interbody threaded cage. J Spinal Disord 1998; 11 : 95- 101. (Pubitemid 28185906)
4. Hecht BP, Fischgrund JS, Herkowitz HN, et al. The use of recombinant human bone morphogenetic protein 2 (rhBMP-2) to promote spinal fusion in a nonhuman primate anterior interbody fusion model. Spine 1999; 24 : 629- 36. (Pubitemid 29162904)
5. Sidhu KS, Prochnow TD, Schmitt P, et al. Anterior cervical interbody fusion with rhBMP-2 and tantalum in a goat model. Spine J 2001; 1 : 331- 40. (Pubitemid 33377772)
6. Sandhu HS, Tonth JM, Diwan AD, et al. Histologic evaluation of the efficacy of rhBMP-2 compared with autograft bone in sheep spinalanterior interbody fusion. Spine 2002; 27 : 567- 75.
7. Boden SD, Kang J, Sandhu H, et al. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in human. Spine 2002; 27 : 2662- 73.
8. Haid RW, Branch CL Jr, Alexander JT, et al. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages. Spine J 2004; 4 : 527- 39.
9. Burkus JK, Sandhu HS, Gornet MF, et al. Use of rhBMP-2 in combination with structural corticalallografts: clinical and radiographic outcomes in anterior lumbar spinal surgery. J Bone Joint Surg Am 2005; 87 : 1205- 12.
10. Glassman SD, Dimar JR, Carreon LY, et al. Initial fusion rates with recombinant human bone morphogenetic protein-2/compression resistant matrix and a hydroxyapatite and tricalcium phosphate/collagen carrier in posterolateral spinal fusion. Spine 2005; 30 : 1694- 8.
11. Singh K, Smucker JD, Boden SD. Use of recombinant human bone morphogenetic protein-2 as an adjunct in posterolateral lumbar spine fusion: a prospective CY-scan analysis at one and two years. Spinal Disord Tech 2006; 19 : 416- 23.
12. Dimar JR, Glassman SD, Burkus KJ, et al. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft. Spine 2006; 31 : 2534- 9. (Pubitemid 44632234)
13. Slosar PJ, Josey R, Reynolds J. Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes. Spine J 2007; 7 : 301- 7.
14. Maeda T, Buchowski JM, Kim YJ, et al. Long adult spinal deformity fusion to the sacrum using rhBMP-2 versus autogenous iliac crest bone graft. Spine 2009; 34 : 2205- 12.
15. Kim YJ, Bridwell KH, Lenke LG, et al. Pseudarthrosis in primary fusions for adult idiopathic scoliosis: risk factors, and outcome analysis. Spine 2005; 30 : 468- 74.
16. Kim YJ, Bridwell KH, Lenke LG, et al. Pseudarthrosis in adult spinal deformity following multisegmental instrumentation and arthrodesis. J Bone Joint Surg Am 2006; 88 : 721- 8.
17. Kim YJ, Bridwell KH, Lenke LG, et al. Pseudarthrosis in long adult spinal deformity instrumentation and fusion to the sacrum: prevalence and risk factor analysis of 144 cases. Spine 2006; 31 : 2329- 36. (Pubitemid 44423532)
18. Lapp MA, Bridwell KH, Lenke LG, et al. Long-term complications in adult spinal deformity patients having combined surgery: a comparison of primary to revision patients. Spine 2001; 26 : 973- 83.
19. Weistroffer JK, Perra JH, Lonstein JE, et al. Complication in long fusions to the sacrum for adult scoliosis. Spine 2008; 33 : 1478- 83.
20. Grob D, Scheier HJ, Dvorak J, et al. Circumferential fusion of the lumbar and lumbosacral spine. Arch Orthop Trauma Surg 1991; 111 : 20- 5.
21. Luhmann SJ, Bridwell KH, Cheng I, et al. Use of bone morphogenetic protein-2 for adult spinal deformity. Spine 2005; 30 :S110- 7. (Pubitemid 41292212)
22. McKay B, Sandhu HS. Use of recombinant human bone morphogenetic protein-2 in spinal fusion application. Spine 2002; 27 ( suppl ): S66- 85.
23. Shields LB, Raque GH, Glassman SD, et al. Adverse effects associated with high-dose recombinant human bone morphogenetic protein- 2 use in anterior cervical spine fusion. Spine 2006; 31 : 542- 7.
24. Smucker JD, Rhee JM, Singh K, et al. Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine. Spine 2006; 31 : 2813- 9. (Pubitemid 44772783)
25. McClellan JW, Mulconrey DS, Forbes RJ, et al. Vertebral bone resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2). J Spinal Disord Tech 2006; 19 : 483- 6.
26. Lewandrowski KU, Nanson C, Calderon R. Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: a report of 5 cases. Spine J 2007; 7 : 609- 14.
27. Harrington JF, Sampath P. Complications of minimally invasive lumbar interbody fusion. In: Joint Section on Disorders of the Spine and Peripheral Nerves (AANS/CNS). 23rd Annual Meeting; March 7-10, 2007; Phoenix, AZ.
28. Williams BJ, Smith JS, Fu KM, et al. Scoliosis Research Society Morbidity and Mortality Committee. Does bone morphogenetic protein increase the incidence of perioperative complications in spinal fusion? A comparison of 55, 862 cases of spinal fusion with and without bone morphogenetic protein. Spine (Phila Pa 1976) 2011; 36 : 1685- 91.